A study in Northern Savonia reveals that medication errors in Finland could potentially cost over 150 million euros a year, with only a small fraction of these errors being reported.
A research team from the Northern Savonia welfare region has conducted a pioneering study in Finland to quantify the financial and time costs of medication errors within the healthcare system annually. The study found that reported medication errors in Northern Savonia alone incurred costs of approximately 686,000 euros in 2023. When extrapolating these findings to a national level, the estimated annual costs rise to 15.5 million euros.
Pharmaceutical doctor Jonna-Carita Kanninen, who serves as the research director at Northern Savonia's hospital pharmacy, emphasizes that the actual figures are likely much higher since only about ten percent of medication errors are reported. Based on this reporting rate, the estimated costs in Northern Savonia could be nearly seven million euros, while nationwide, the figure could exceed 150 million euros each year. This underreporting indicates a significant issue within the healthcare system that needs to be addressed.
Kanninen's comments suggest that there is considerable potential for reducing these errors, which speaks to broader implications for patient safety and healthcare efficiency in Finland. The study highlights the urgent need for better reporting mechanisms and strategies to minimize medication errors, which not only burdens the healthcare system financially but also affects patient well-being. Improving these practices could lead to substantial healthcare savings and improved outcomes for patients across the country.
